The first exon on the BCR domain contains tyrosine 177 (Y177), which activates the transforming potential of the cells and synergistically promotes CML cell expansion, proliferation and survival. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.